Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viruses and vascular disease

Y Yonemitsu

    Nature Medicine
    |March 21, 1998
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

    Journal of viral hepatitis·2014
    Same author

    Hemagglutinating virus of Japan liposome-mediated gene delivery to vascular cells.

    Methods in molecular medicine·2011
    Same author

    Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.

    Journal of viral hepatitis·2010
    Same author

    Semi-allogeneic dendritic cells injected via the intratumoural injection route show efficient antitumour effects in cooperation with host-derived professional antigen-presenting cells.

    Scandinavian journal of immunology·2010
    Same author

    Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.

    Gene therapy·2008
    Same author

    Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.

    Gene therapy·2008
    Same journal

    Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

    Nature medicine·2026
    Same journal

    Immune aging biomarkers for clinical trials.

    Nature medicine·2026
    Same journal

    Lassa fever countermeasures gather pace.

    Nature medicine·2026
    Same journal

    Why high scores do not mean application readiness for health AI.

    Nature medicine·2026
    Same journal

    Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

    Nature medicine·2026
    Same journal

    Biological aging might help to explain the rising risk of early-onset cancer.

    Nature medicine·2026
    See all related articles